Christian K. O. Dzuvor

This study uses flow virometry to analyze spike antigenicity of endemic human coronaviruses, revealing cell line-dependent differences and heterogeneity not captured by bulk assays.

This paper designs and evaluates nanoparticle vaccines with optimized linkers to enhance cross-reactive antibody responses against coronaviruses and other viral families.

This study identifies mAbs targeting HCoV-HKU1 spike protein and shows that receptor-binding site recognition alone does not predict neutralization in primary cells.

The paper designs multiclade coronavirus spike immunodominant domain nanoparticles that elicit broad antibody responses against multiple EhCoVs and SARS-CoV-2 variants in mice.